WEDNESDAY, July 22 (HealthDay News) -- New information about a
cellular protein might help in efforts to develop drug treatments for
diabetes and Alzheimer's disease, researchers say.

In tests on rats, they found that humanin, which may prevent nerve
cells from dying, also helps improve insulin action and lower blood
glucose levels.

"This new role of humanin in glucose metabolism, in addition to its
role in Alzheimer's disease, is very intriguing since scientists have long
proposed a link between type 2 diabetes and Alzheimer's disease," Dr. Nir
Barzilai, a professor and director of the Institute for Aging Research at
the Albert Einstein College of Medicine in New York City, said in a news
release from the college.

"Humanin could turn out to be a therapeutic option for two common
debilitating diseases that affect millions of people, Barzilai said.
"Additionally, humanin may help treat other age-related diseases."

The study appears online July 22 in PLoS One.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.